Results 51 to 60 of about 204,436 (364)
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021 Background Patients with recurring heart failure (HF) following cardiac resynchronization therapy fare poorly. Their management is undecided. We tested remote hemodynamic‐guided pharmacotherapy.
N. Varma +8 more
semanticscholar +1 more source
Advances in Cardiac Resynchronization Therapy [PDF]
Journal of Innovations in Cardiac Rhythm Management, 2019 The development of cardiac resynchronization therapy (CRT) has been crucial in reducing morbidity and mortality in patients with advanced heart failure. However, a significant proportion of patients who receive CRT fail to derive significant clinical benefits from this therapy.
Miguel A. Leal, Asif Jafferani
openaire +2 more sources
Influence of diabetes on cardiac resynchronization therapy in heart failure patients: a meta-analysis [PDF]
, 2015 BACKGROUND: Diabetes mellitus is an independent risk factor of increased morbidity and mortality in patients with heart failure. Cardiac resynchronization therapy (CRT), a pacemaker-based therapy for dyssynchronous heart failure, improves cardiac ...
Guohai Su +11 more
core +1 more source
Predictors of Cardiac Resynchronization Therapy Response: The Pivotal Role of Electrocardiogram
The Scientific World Journal, 2013 Heart failure affects millions of patients all over the world, and its treatment is a major clinical challenge. Cardiac dyssynchrony is common among patients with advanced heart failure.
Yahya S. Al Hebaishi +2 more
doaj +1 more source
Early indication of decompensated heart failure in patients on home-telemonitoring: a comparison of prediction algorithms based on daily weight and noninvasive transthoracic bio-impedance [PDF]
, 2016 Background: Heart Failure (HF) is a common reason for hospitalization. Admissions might be prevented by early detection of and intervention for decompensation. Conventionally, changes in weight, a possible measure of fluid accumulation, have been used to
Amft, Oliver +6 more
core +2 more sources
Surgical Case Reports, 2020 Background In a Fontan candidate, univentricular pacing may cause delay in interventricular conduction, which induces asynchronous contraction. Cardiac resynchronization therapy is expected to be an effective mode of therapy in such a case.
Ai Sugimoto +4 more
doaj +1 more source
Cardiac Resynchronization Therapy Leads to Improvements in Handgrip Strength [PDF]
, 2016 Background: A reduction in skeletal muscle performance measured by handgrip strength is common in heart failure. No trial has investigated the role of cardiac resynchronization therapy, which leads to improvements in cardiac performance, on the ...
Lawford, P. +2 more
core +1 more source
Iatreia, 2016 Objective: To evaluate survival in patients with cardiac resynchronization with or without cardioverterdefibrillator versus patients with implantable cardioverter-defibrillator alone Materials and methods: Retrospective cohort, the primary end point was ...
Arango- Franco, Ricardo +9 more
doaj +1 more source
Imaging Cardiac Resynchronization Therapy
JACC: Cardiovascular Imaging, 2009 Although a prognostic benefit has been shown from cardiac resynchronization therapy, questions are often directed toward the prediction of symptomatic or functional benefit. Recent multicenter trials have shown the pitfalls of current mechanical markers of left ventricular synchrony, but these negative trial results have not marked the conclusion of ...
Abraham, Theodore +6 more
openaire +5 more sources
Türk Kardiyoloji Derneği Arşivi, 2013 Hypertrophic cardiomyopathy (HCM) is characterized by heterogeneous clinical expression. Cardiac transplantation continues to be the gold standard for the treatment of end-stage cardiac diseases refractory to medical therapy.
Ahmet Vural +2 more
doaj +1 more source